I am a biomedical researcher with a multidisciplinary interest in molecular biology, oncology, and metabolic diagnostics. My work primarily focuses on cancer biology, particularly exploring metabolic epigenomic reprogramming in cancer models using MCF-7 cell lines, and investigating ferroptosis and ferroptosis-associated cell death mechanisms as emerging therapeutic strategies in oncology. I’m also actively integrating machine learning-based tools into biomedical diagnostics, with projects like fingernail impression analysis for metabolic disorder detection. Beyond the lab, I had collaborated with health-tech services to bridge the gap between metabolomic profiling, biosensor innovations, and clinical application. I’ve had the opportunity to present my work at national and international conferences, contributing to the growing conversation around cancer therapeutics, ferroptosis research, metabolic health, and biomedical innovation.